Genes and Variants Underlying Human Congenital Lactic Acidosis—From Genetics to Personalized Treatment

Congenital lactic acidosis (CLA) is a rare condition in most instances due to a range of inborn errors of metabolism that result in defective mitochondrial function. Even though the implementation of next generation sequencing has been rapid, the diagnosis rate for this highly heterogeneous allelic condition remains low. The present work reports our group’s experience of using a clinical/biochemical analysis system in conjunction with genetic findings that facilitates the taking of timely clinical decisions with minimum need for invasive procedures. The system’s workflow combines different metabolomics datasets and phenotypic information with the results of clinical exome sequencing and/or RNA analysis. The system’s use detected genetic variants in 64% of a cohort of 39 CLA-patients; these variants, 14 of which were novel, were found in 19 different nuclear and two mitochondrial genes. For patients with variants of unknown significance, the genetic analysis was combined with functional genetic and/or bioenergetics analyses in an attempt to detect pathogenicity. Our results warranted subsequent testing of antisense therapy to rescue the abnormal splicing in cultures of fibroblasts from a patient with a defective GFM1 gene. The discussed system facilitates the diagnosis of CLA by avoiding the need to use invasive techniques and increase our knowledge of the causes of this condition.

[1]  M. Zeviani,et al.  Inhibition of proteasome rescues a pathogenic variant of respiratory chain assembly factor COA7 , 2019, EMBO molecular medicine.

[2]  Pedro Rebelo-Guiomar,et al.  Pathogenic variants in glutamyl-tRNAGln amidotransferase subunits cause a lethal mitochondrial cardiomyopathy disorder , 2018, Nature Communications.

[3]  R. Horvath,et al.  Mitochondrial DNA transcription and translation: clinical syndromes , 2018, Essays in biochemistry.

[4]  M. Zeviani,et al.  Human diseases associated with defects in assembly of OXPHOS complexes , 2018, Essays in biochemistry.

[5]  Alexandros Kouris,et al.  VarSome: the human genomic variant search engine , 2018, bioRxiv.

[6]  P. Chinnery,et al.  First-line genomic diagnosis of mitochondrial disorders , 2018, Nature Reviews Genetics.

[7]  R. Rodenburg,et al.  Effectiveness of whole exome sequencing in unsolved patients with a clinical suspicion of a mitochondrial disorder in Estonia , 2018, Molecular genetics and metabolism reports.

[8]  M. Minczuk,et al.  New insights into the phenotype of FARS2 deficiency , 2017, Molecular genetics and metabolism.

[9]  R. Horvath,et al.  Revisiting mitochondrial diagnostic criteria in the new era of genomics , 2017, Genetics in Medicine.

[10]  Marni J. Falk,et al.  Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society , 2017, Genetics in Medicine.

[11]  C. Pérez-Cerdá,et al.  Nonketotic hyperglycinemia: Functional assessment of missense variants in GLDC to understand phenotypes of the disease , 2017, Human mutation.

[12]  J. Shendure,et al.  Activation of a cryptic splice site in the mitochondrial elongation factor GFM1 causes combined OXPHOS deficiency. , 2017, Mitochondrion.

[13]  Thomas Meitinger,et al.  Genetic diagnosis of Mendelian disorders via RNA sequencing , 2017, Nature Communications.

[14]  Ines Thiele,et al.  Leigh map: A novel computational diagnostic resource for mitochondrial disease , 2017, Annals of neurology.

[15]  Shuling Guo,et al.  Use of antisense oligonucleotides to correct the splicing error in ISCU myopathy patient cell lines. , 2016, Human molecular genetics.

[16]  E. Ruiz-Pesini,et al.  Molecular-genetic characterization and rescue of a TSFM mutation causing childhood-onset ataxia and nonobstructive cardiomyopathy , 2016, European Journal of Human Genetics.

[17]  V. Tiranti,et al.  New genes and pathomechanisms in mitochondrial disorders unraveled by NGS technologies. , 2016, Biochimica et biophysica acta.

[18]  Paul D. Thomas,et al.  PANTHER-PSEP: predicting disease-causing genetic variants using position-specific evolutionary preservation , 2016, Bioinform..

[19]  Günther Specht,et al.  mtDNA-Server: next-generation sequencing data analysis of human mitochondrial DNA in the cloud , 2016, Nucleic Acids Res..

[20]  B. Merinero,et al.  Mitochondrial response to the BCKDK-deficiency: Some clues to understand the positive dietary response in this form of autism. , 2016, Biochimica et biophysica acta.

[21]  B. Merinero,et al.  Dataset reporting BCKDK interference in a BCAA-catabolism restricted environment , 2016, Data in brief.

[22]  C. Pérez-Cerdá,et al.  Molecular diagnosis of glycogen storage disease and disorders with overlapping clinical symptoms by massive parallel sequencing , 2016, Genetics in Medicine.

[23]  Y. Okazaki,et al.  A Comprehensive Genomic Analysis Reveals the Genetic Landscape of Mitochondrial Respiratory Chain Complex Deficiencies , 2016, PLoS genetics.

[24]  J. Rioux,et al.  A Metabolic Signature of Mitochondrial Dysfunction Revealed through a Monogenic Form of Leigh Syndrome , 2015, Cell reports.

[25]  Ann E. Frazier,et al.  Characterization of mitochondrial FOXRED1 in the assembly of respiratory chain complex I. , 2015, Human molecular genetics.

[26]  Robert W. Taylor,et al.  Long-term survival in a child with severe encephalopathy, multiple respiratory chain deficiency and GFM1 mutations , 2015, Front. Genet..

[27]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[28]  Richard J. Rodenburg,et al.  Whole exome sequencing of suspected mitochondrial patients in clinical practice , 2015, Journal of Inherited Metabolic Disease.

[29]  E. Trevisson,et al.  Genetic bases and clinical manifestations of coenzyme Q10 (CoQ10) deficiency , 2015, Journal of Inherited Metabolic Disease.

[30]  Joaquín Dopazo,et al.  Two Novel Mutations in the BCKDK (Branched‐Chain Keto‐Acid Dehydrogenase Kinase) Gene Are Responsible for a Neurobehavioral Deficit in Two Pediatric Unrelated Patients , 2014, Human mutation.

[31]  E. Bertini,et al.  Persistent pulmonary arterial hypertension in the newborn (PPHN): a frequent manifestation of TMEM70 defective patients. , 2014, Molecular genetics and metabolism.

[32]  D. Grinberg,et al.  Antisense mediated splicing modulation for inherited metabolic diseases: challenges for delivery. , 2014, Nucleic acid therapeutics.

[33]  Li Chieh Chen,et al.  Transition to Next Generation Analysis of the Whole Mitochondrial Genome: A Summary of Molecular Defects , 2013, Human mutation.

[34]  B. Merinero,et al.  A Novel Regulatory Defect in the Branched‐Chain α‐Keto Acid Dehydrogenase Complex Due to a Mutation in the PPM1K Gene Causes a Mild Variant Phenotype of Maple Syrup Urine Disease , 2013, Human mutation.

[35]  A. Munnich,et al.  Toward genotype phenotype correlations in GFM1 mutations. , 2012, Mitochondrion.

[36]  Robert W. Taylor,et al.  Respiratory chain complex I deficiency caused by mitochondrial DNA mutations , 2011, European Journal of Human Genetics.

[37]  Predrag Radivojac,et al.  Automated inference of molecular mechanisms of disease from amino acid substitutions , 2009, Bioinform..

[38]  L. Salviati,et al.  Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. , 2008, The New England journal of medicine.

[39]  C. Pérez-Cerdá,et al.  Separation and identification of plasma short-chain acylcarnitine isomers by HPLC/MS/MS for the differential diagnosis of fatty acid oxidation defects and organic acidemias. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[40]  Pierre Baldi,et al.  An enhanced MITOMAP with a global mtDNA mutational phylogeny , 2006, Nucleic Acids Res..

[41]  R. Rodenburg,et al.  Mitochondrial disease criteria , 2006, Neurology.

[42]  S. Dimauro,et al.  Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: A CoQ10-responsive condition , 2005, Neurology.

[43]  M. Sheetz,et al.  Mitochondrial Function and Actin Regulate Dynamin-Related Protein 1-Dependent Mitochondrial Fission , 2005, Current Biology.

[44]  Francisco E. Baralle,et al.  Genomic variants in exons and introns: identifying the splicing spoilers , 2004, Nature Reviews Genetics.

[45]  A. Ribes,et al.  Free-thiamine is a potential biomarker of thiamine transporter-2 deficiency: a treatable cause of Leigh syndrome. , 2016, Brain : a journal of neurology.

[46]  S. Dimauro,et al.  Mitochondrial diseases , 2016, Nature Reviews Disease Primers.

[47]  A. S. Relman.  Lactic acidosis. , 1971, Transactions of the American Clinical and Climatological Association.